Diagnosing Rare Childhood Diseases
Rapid whole-genome sequencing is making a difference for acutely ill newborns.
Read MorePosted by Elaine Sanchez Wilson | Mar 28, 2018 | Disease States |
Rapid whole-genome sequencing is making a difference for acutely ill newborns.
Read MorePosted by Elaine Sanchez Wilson | Mar 21, 2018 | Standards |
With its acquisition of Maine Biotechnology Services, BBI Solutions has added more than 80 new antibodies to its growing product portfolio, as well as custom antibody development services.
Read MorePosted by Elaine Sanchez Wilson | Mar 21, 2018 | Blood Gas Analyzers, Clinical Chemistry, POC Rapid Assays |
Siemens Healthineers has received FDA premarket notification clearance for its blood urea nitrogen and total carbon dioxide point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.
Read MorePosted by Elaine Sanchez Wilson | Mar 14, 2018 | Research |
As part of its breakthrough devices program, FDA reviewed and authorized for marketing the Banyan Brain Trauma Indicator from Banyan Biomarkers in less than 6 months.
Read MorePosted by Elaine Sanchez Wilson | Mar 12, 2018 | Software |
Promoted as a complete sample-to-insight solution, the Qiagen GeneReader NGS system comprises all elements of an NGS workflow.
Read More